In a recent monologue, the comedian James Corden addressed his struggles with being overweight. Despite his best efforts, he said, he has never been able to control his weight confessing that he has good days and bad months. The monologue was a response to an on-air editorial by Bill Maher, who argued that fat shaming needs to make a comeback, excoriating the obese for their lack of self-control. Which of them was correct? Are the obese to blame for their condition?
No. Recent research has revealed that obesity is to a very large extent encoded in our genes. Indeed, studies of identical twins reveal that the heritability of obesity ranges between 7080 percent, a level that is exceeded only by height and is greater than for many conditions that people accept as having a genetic basis. While there has also been an overall increase in the prevalence of obesity over the last several decades, it is the particular set of weight-regulating genes that a person inherits that determines who is lean and who is obese in 2019 America.
Could it be then, as Maher implies, that thin people control their urge to eat and the obese do not? For those who believe that being thin is a result of greater self-control, consider the case of a massively obese four-year-old boy in England, who weighed 80 pounds. After consuming a single test meal of 1,125 calories (half the daily intake of an average adult), he asked for more. This boy had a similarly affected eight-year-old cousin who weighed more than 200 pounds. Both children carry a genetic defect causing their obesity that runs in the family. The defective gene encodes the adipocyte hormone leptin, and the children do not produce it.
However, when they receive leptin injections, their appetite is reduced to normal, and they lose enormous amounts of weight. The boy in fact is now quite thin. These findings confirm that biologic factors play the key role in determining ones appetite undercutting the common misconception that food intake is primarily under voluntary control.
In normal people without leptin mutations, the hormone is secreted by fat cells into the bloodstream and then acts on specialized brain cells that regulate appetite. When the amount of fat increases, leptin production increases, and food intake goes down. When weight is lost, leptin decreases, which then stimulates appetite. This physiologic system acts in a manner analogous to a thermostat (or lipostat) that maintains body weight within a relatively narrow range.
This system serves a vital evolutionary function by maintaining optimal levels of adipose tissue, thus providing a source of calories when food is not available, a not uncommon occurrence during human evolution. However, the decreased mobility associated with excess fat can increase the risk posed by predators. The leptin system appears to have evolved to balance the risk of being too thin (starvation) and the risk of being too obese (predation). Indeed, the weight of all mammals is precisely regulatednotwithstanding that only humans have ever expressed a conscious desire to lose weight.
Specific genetic differences that predispose to obesity or leanness are then propagated by natural selection depending on whether starvation or predation was the greater risk. The weight of each individual is then stably maintained by the leptin system with remarkable precision. The average person takes in a million or more calories per year, maintaining weight within a narrow range over the course of decades. The body balances calorie consumption with expenditure, and with accuracy greater than 99.5 percenta precision far greater even than that on labels showing the calorie content of the food we eat.
Mutations in hormones are rare and there are only a few dozen patients who fail to produce leptin. So, while studies of these individuals establish a role for leptin to control appetite in human, defects in the gene itself are a very infrequent cause of obesity. However, mutations in the neural circuit that is regulated by leptin are more common, including mutations in the receptor for leptin. Patients with mutations cannot receive leptins signal and so also become massively obese. But because these patients cannot receive leptins signal, treatment with the hormone is ineffective and these patients are referred to as being leptin resistant.
The leptin receptor is expressed in the hypothalamus, a primitive part of the brain that regulates most basic biologic drives, including the basic drive to eat. In the hypothalamus, there are specialized neurons expressing the leptin receptor that regulate appetite. One type promotes food intake; a second neural population reduces food intake. Leptin acts by inhibiting the one and activating the other. Similar to mutations in the leptin receptor, mutations in other key genes downstream of the hypothalamus also cause human obesity. Recent genetic studies have shown that as many as 10 percent of markedly obese children carry mutations in one or another of these individual genes. Thus, when Maher categorically asserts that obesity isnt a birth defect, he is (mostly) wrong.
Another mistake that Maher and others make is to assume that the drive to eat is the same for all. Leptin regulates the intensity of the feeding drive. In its absence, patients report being unable to control their appetite and eat voraciously. One patient described it as hunger without end, akin to the hungriest youve ever been. That is how leptin deficient people feel all the time. This sensation appears to be similar for obese patients who lose weight (e.g., The Biggest Loser), the majority of whom put the weight back on
In aggregate, the genes that control food intake and metabolism act to keep weight in a stable range by creating a biological force that resists weight change in either direction. Moreover, the greater the amount of weight that is lost, the greater the sense of hunger that develops. So, when the obese lose large amounts of weight by conscious effort, their bodies fight back with a vengeance. If you think it is difficult to lose15 pounds, imagine what it must feel like to lose 50 or 100!
Can willpower restrain this drive over the long term? The evidence says that for the vast majority of people the answer is no. Yes, a relatively small proportion of patients do maintain long term weight loss. But willpower is not metaphysical, it is encoded in our cerebral cortex, where conscious thought resides. How the cortex successfully communicates with the hypothalamus varies among individuals. The precise ways that this communication happens is not yet known but is an area of active investigation.
What we do know tells us that if you are thin, you should thank your "lean" genes and refrain from stigmatizing the obese. A broad acceptance of the biologic basis of obesity would not only be fair but would allow us to collectively focus on health. Even modest amounts of weight loss, far less than would satisfy Maher, can improve health and this should be the objective for obese people who suffer from its medical complications.
While research is moving toward developing effective therapies for obesity, we are not there yet. In the meantime, we must change our attitudes and turn our focus from appearance and to improved health. The obese are fighting against their biology. But they also are fighting against a society that wrongly believes that being fat is a shameful, personal failing.
Here is the original post:
Obesity Is in the Genes - Scientific American
- Patients with Severe Forms of Coronavirus Disease Could Offer Clues to Treatment - Howard Hughes Medical Institute - March 26th, 2020
- Clean your phone 'at least once a day,' medical experts say. Here's howwithout damaging the screen - CNBC - March 26th, 2020
- Castle Creek Biosciences Announces $75 Million Investment to Advance Development of Multiple Gene Therapy Candidates for Rare Diseases - Yahoo Finance - March 26th, 2020
- Bridging the gap study sequences Asian genomes to diversify genetic databases - University of Virginia The Cavalier Daily - March 26th, 2020
- Coronavirus Treatment: Hundreds of Scientists Scramble to Find One - The New York Times - March 26th, 2020
- AZ adds gene silencing tech to pipeline with Silence Therapeutics deal - - pharmaphorum - March 26th, 2020
- A coronavirus test can be developed in 24 hours. So why are some countries still struggling to diagnose? - CNN - March 26th, 2020
- Vycellix and Avectas Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies - BioSpace - March 26th, 2020
- Meet a superhero that fights breast cancer, neurofibromin - Baylor College of Medicine News - March 26th, 2020
- Twelve Women Who Have Shaped The History of the BioHealth Capital Region - BioBuzz - March 26th, 2020
- Study reveals gene therapy may help in treating cardiac disease - The Siasat Daily - March 26th, 2020
- Alnylam Pharmaceuticals and Gen Sign Distribution Agreement in Turkey for ONPATTRO (patisiran), the First-in-Class Gene-Silencing RNAi Therapeutic -... - March 26th, 2020
- Covid-19: Why testing takes time and what to expect - Daily Maverick - March 26th, 2020
- Gene editing might help restore extinct plants used as food, medicine and perfume thousands of years ago - Genetic Literacy Project - March 23rd, 2020
- A new AI system has enabled the discovery of a novel role for 'smell-sensing' genes in colon cancer - Healthcare IT News - March 23rd, 2020
- Invitae and Muscular Dystrophy Association (MDA) Expand Access to No-Charge Genetic Testing in the US and Canada - PRNewswire - March 23rd, 2020
- Amicus Therapeutics Confirms Business Continuity, 2020 Strategic Priorities and Announces Proactive Efforts to Support Public Health Initiatives,... - March 23rd, 2020
- Genetron Health Contributes to China's First Expert Consensus Statement on the Standardized Clinical Application of NGS Testing for Oncology -... - March 23rd, 2020
- HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies -... - March 21st, 2020
- Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients | NDT - Dove Medical Press - March 21st, 2020
- Novel Discovery of "Hidden" Gene Within a Gene in Mammals - Technology Networks - March 21st, 2020
- Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic... - March 21st, 2020
- Fact check: Were elderly Italians left to die? And is socialized health care to blame? - USA TODAY - March 21st, 2020
- Why There Aren't Enough Coronavirus Tests in the U.S. - Popular Mechanics - March 21st, 2020
- AskBio Enters Research Collaboration and Licensing Agreement with University of North Carolina (UNC) for Angelman Syndrome - Associated Press - March 21st, 2020
- CRISPR Used To Edit Genes Inside A Patient With A Rare Form Of Blindness : Shots - Health News - NPR - March 5th, 2020
- Gene and cell therapies continue growth in patients, financing, and costs - STAT - March 5th, 2020
- Editas and Allergan Make Gene-Editing History With First Treatment of Blindness Drug - The Motley Fool - March 5th, 2020
- A snapshot of the precision medicine landscape - MedCity News - March 5th, 2020
- Allergan and Editas Medicine Announce Dosing of First Patient in Landmark Phase 1/2 Clinical Trial of CRISPR Medicine AGN-151587 (EDIT-101) for the... - March 5th, 2020
- Sysmex : and the Kobe City Eye Hospital Sign a Comprehensive Collaboration Agreement -Reinforcing Collaboration toward the Realization of Genomic... - March 5th, 2020
- Biochemical and structural cues of 3D-printed matrix synergistically direct MSC differentiation for functional sweat gland regeneration - Science... - March 5th, 2020
- GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery - Business Wire - December 13th, 2019
- Personalized CF Medicine to be Tested for Rare Genetic Defects in Europe - Cystic Fibrosis News Today - December 13th, 2019
- Experts Forum: Creating a cluster of innovation in Rochester - Finance and Commerce - December 13th, 2019
- Sarepta Therapeutics Announces $250 Million of Non-Dilutive Senior Secured Loan Financing - GlobeNewswire - December 13th, 2019
- Care Coordination and Precision Medicine Improve Early Diagnoses - HealthPayerIntelligence.com - December 13th, 2019
- Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease - P&T... - December 13th, 2019
- Would you pay $2.1 million for one-off gene therapy? - Kalkine Media - December 13th, 2019
- The genetic mutation behind a new autoinflammatory disease - Pursuit - December 13th, 2019
- New Anti-Aging Clinical Trial Begins. For $1 Million, You Can Be a Participant. - Livescience.com - December 13th, 2019
- Updates from SABCS 2019: Detection and Screening, Immunotherapy Advances, and Therapy Resistance - On Cancer - Memorial Sloan Kettering - December 13th, 2019
- Researchers unfold genetic code that controls cell function and disease - BSA bureau - December 13th, 2019
- Our shockingly short lives without modern medicine revealed - Newshub - December 13th, 2019
- First look at CRISPR, Vertex gene-editing therapy hints at treatment potential - BioPharma Dive - November 23rd, 2019
- Applying AI and CRISPR to stem cells to improve regenerative medicine - FierceBiotech - November 23rd, 2019
- Will a Treatment for Alzheimer's Ever Be Found? - Columbia University Irving Medical Center - November 23rd, 2019
- This Mom Is Buying Mutant Mice From China To Find A Cure For Her Sons Rare Genetic Disease - BuzzFeed News - November 23rd, 2019
- These Scientists May Have Found a Cure for 'Bubble Boy' Disease - Smithsonian.com - November 23rd, 2019
- Calculating the Spatial Pattern of Gene Expression for the Entire Genome - Technology Networks - November 23rd, 2019
- Gene linked to Alzheimers disease plays indirect role in risk for... - ScienceBlog.com - November 23rd, 2019
- A Reflection On BTD And RMAT Designations - Pink Sheet - November 23rd, 2019
- Nature vs Nurture: What's Fueling the Obesity Epidemic? - Medscape - November 23rd, 2019
- Sniffing Out Cancer in Canines And Humans, Too - NC State News - November 23rd, 2019
- A Rare Genetic Disorder Turned These Siblings' Blood 'Milky' White - Livescience.com - November 23rd, 2019
- To Improve Public Health, Medicine Regulators Worldwide Should Collaborate, Remove Barriers to Sharing Information, Says New Report - National... - November 21st, 2019
- The Medicine Plant That Could Have Changed the World. - The National Interest Online - November 21st, 2019
- Consumer DNA Testing May Be the Biggest Health Scam of the Decade - Gizmodo - November 21st, 2019
- Genetically Modified Babies? Possible Within the Next Two Years, Scientists Claim - Nature World News - November 21st, 2019
- A 17-gene expression signature to distinguish patients who are likely to achieve long-term remissions following front-line FCR chemoimmunotherapy from... - November 21st, 2019
- UC Davis leads in innovative gene editing research with NIH grants - The Aggie - November 21st, 2019
- New research casts doubt on near reality of 'designer babies' - PRNewswire - November 21st, 2019
- Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis - BioSpace - November 21st, 2019
- Global Cancer Biomarkers Market, Forecast to 2026 - Emerging Economies & Personalized Medicine to Provide Ample Industry Opportunities -... - November 21st, 2019
- This miracle drug was designed and manufactured for just one person a 9-year-old Boulder girl - The Colorado Sun - November 21st, 2019
- Novartis' Zolgensma gene therapy study halted on animal safety concerns - STAT - October 31st, 2019
- Gene therapy gives toddler second chance | Indiana | Journal Gazette - Fort Wayne Journal Gazette - October 31st, 2019
- Ruanne Vent-Schmidt: The blind and visually impaired can help researchers by getting their genes tested - Vancouver Sun - October 31st, 2019
- Soon, genetic testing for cancer treatment could match you with the perfect drug - NorthJersey.com - October 31st, 2019
- Alcohol intake and reduced brain volume: What explains the link? - Medical News Today - October 31st, 2019
- Genome Sequencing In NICU Can Speed Diagnosis Of Rare Inherited Diseases : Shots - Health News - NPR - October 31st, 2019
- Charting the evolution of diabetes research and care | Speaking of Medicine - PLoS Blogs - October 31st, 2019
- Huntington's Marked by Inflammation and Changes in Brain's Striatum Before Symptoms, Study Finds - Huntington's Disease News - October 31st, 2019
- Gene Lee: 5 Fast Facts You Need to Know - Heavy.com - October 31st, 2019
- Gene Expression Market to Reach USD 11.37 Billion by 2026 | Reports and Data - P&T Community - October 15th, 2019
- Gene therapy for Duchenne muscular dystrophy safely preserves muscle function - Penn: Office of University Communications - October 15th, 2019
- Global Neurodegenerative Disorder Therapeutics Market 2019-2024: Opportunities in Digital Biomarkers, Microbiome Therapeutics, Cell and Gene Therapy,... - October 15th, 2019
- Food As Medicine: What Biochemistry And Genetics Are Teaching Us About How To Eat Right - Forbes - October 15th, 2019
- Some cases of SIDS may have this genetic cause - Futurity: Research News - October 15th, 2019
- The 2019 Nobel Prize In Medicine: Here Is What Won The Award - Forbes - October 15th, 2019